Efficacy of indacaterol/glycopyrronium/mometasone (IND/GLY/MF) vs free combination of salmeterol/fluticasone (SAL/FLU) & tiotropium (TIO) in patients with uncontrolled asthma on prior LABA/ICS high-dose (GINA step 5): Results from ARGON study

Source: International Congress 2022 – Clinical treatment of asthma

Session: Clinical treatment of asthma
Session type: Thematic Poster
Number: 3864

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Gessner (Leipzig, Germany), D. Lawrence (Basel, Switzerland), K. Mezzi (Basel, Switzerland), D. Brittain (Basel, Switzerland), R. Van-Zyl Smit (CapeTown, South Africa). Efficacy of indacaterol/glycopyrronium/mometasone (IND/GLY/MF) vs free combination of salmeterol/fluticasone (SAL/FLU) & tiotropium (TIO) in patients with uncontrolled asthma on prior LABA/ICS high-dose (GINA step 5): Results from ARGON study. 3864

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
• Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
• Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study